Nicki Thompson

Nicki Thompson is a seasoned executive in the biotechnology sector, currently serving as Chair of the Board of Directors at Camena Bioscience since November 2023. Previously, Nicki held the position of CEO at Amphista Therapeutics Limited from June 2019 to October 2023, and served as Chair of the Board of Directors and Chief Business Officer for Nanna Therapeutics between April 2017 and June 2020. Additional experience includes roles as CEO of VirionHealth Ltd (March 2016 - June 2018), Chief Business Officer at Phico Therapeutics Ltd (January 2016 - December 2017), VP and Global Head of the Office of External Drug Discovery at Roche (February 2014 - January 2016), and Senior Director of Business Development at GSK (January 2010 - February 2014). Nicki's career began at Syntaxin Ltd as Discovery Head (January 2008 - December 2009). Education includes a Doctor of Philosophy (PhD) in Cell Biology from the University of London, completed between 1997 and 2001.